Swiss pharma giant Novartis mulls sale of its Indian operations
KEYSTONE
Novartis has announced that it is considering various strategic options regarding the future of its Indian subsidiary Novartis India Limited, which is listed on the Bombay stock exchange. These include the possibility of selling its stake in the company.
This content was published on
2 minutes
“This strategic review will include a valuation of the 70.68% stake in the company,” Novartis India Limited said in a statement. This does not include the subsidiary Novartis Healthcare Private Limited, a separate entity wholly owned by the Basel-based group.
The latter includes the Novartis Corporate Center in Hyderabad, the commercial arm of Novartis in India, as well as research and development teams currently conducting clinical trials at more than 300 sites in the country. Novartis says it remains committed to its operations in India, where it employs more than 8100 associates.
There is no guarantee that this strategic review will be concluded in 2024 or that it will result in a transaction, it says.
At the end of December, Novartis India Limited recorded sales of 2.54 billion rupees (CHF26.9 million) in the first nine months of its offbeat financial year. According to Fierce Pharma, a specialised industry website, the Novartis India Limited subsidiary is involved in the distribution of medicines that are no longer protected by patent, particularly in the treatment of bone, pain, immunology and neuroscience.
In 2022, the distribution rights for some of this entity’s medicines were transferred to the Indian company Dr Reddy’s Laboratories, which, according to various Indian media, is among the potential buyers.
Translated from French by DeepL/ac
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
Related Stories
Popular Stories
More
Swiss Politics
Will Switzerland finally do away with imputed rental-value tax on homeowners?
US says Switzerland can order fewer fighter jets amid cost hike
This content was published on
According to the American authorities, a possible reduction in the number of F-35 fighter jets ordered by Switzerland is possible to cushion the unexpected cost increase.
On wolves, ‘priority should be given to scare shots’, says expert
This content was published on
Wolf expert Jean-Marc Landry believes that Swiss Environment Minister Albert Rösti's decision to rely entirely on shooting is short-sighted.
A thousand demonstrators in Swiss capital demand climate justice
This content was published on
The climate crisis is exacerbating injustice around the world, and the current economic system benefits from colonial and patriarchal oppression, said one of the speakers.
Russian drones in Poland have ‘no impact’ on Switzerland: defence minister
This content was published on
According to Swiss Defence Minister Martin Pfister, the intrusion of Russian drones into Polish airspace "shows how unstable the situation in Europe is."
E-cars account for 10.5% of new registrations in the canton of Zug
This content was published on
Nowhere else in Switzerland are electric cars as popular as in Zug. Currently, 10.5 per cent of cars registered in the canton of Zug are purely electric, as new data from the online platform Energie Reporter and Energie Schweiz and Geoimpact show.
ETH climate researcher honoured with the German Environmental Award
This content was published on
Swiss climate researcher Sonia Isabelle Seneviratne from ETH Zurich receives the German Environmental Award 2025. She shares the prize, endowed with 500,000 euros, with the management duo of the steel galvanising company Zinq.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.